Bagheri H - Search Results

1

Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years.

Hauviller L, Eyvrard F, Garnault V, Rousseau V, Molinier L, Montastruc JL, Bagheri H. Hauviller L, et al. Among authors: bagheri h. Eur J Clin Pharmacol. 2016 May;72(5):631-9. doi: 10.1007/s00228-016-2022-4. Epub 2016 Feb 17. Eur J Clin Pharmacol. 2016. PMID: 26884320

2

Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France.

Montastruc JL, Lapeyre-Mestre M, Bagheri H, Fooladi A. Montastruc JL, et al. Among authors: bagheri h. Fundam Clin Pharmacol. 2002 Oct;16(5):343-6. doi: 10.1046/j.1472-8206.2002.00100.x. Fundam Clin Pharmacol. 2002. PMID: 12608357

3

[Adverse drug reactions (ADRs) to antimalarial drugs. Analysis of spontaneous report from the French pharmacovigilance database (1996-2000)].

Angles A, Bagheri H, Montastruc JL, Magnaval JF; Réseau Français des Centres Régionaux de Pharmacovigilance. Angles A, et al. Among authors: bagheri h. Presse Med. 2003 Jan 25;32(3):106-13. Presse Med. 2003. PMID: 12610379 French.

4

[Retrospective analysis of adverse effects of infliximab in a hospital rheumatology service].

Cabou C, Bagheri H, Cantagrel A, Mazières B, Montastruc JL. Cabou C, et al. Among authors: bagheri h. Therapie. 2003 Sep-Oct;58(5):457-62. doi: 10.2515/therapie:2003074. Therapie. 2003. PMID: 14682196 Review. French.

5

Adverse drug reactions to anthelmintics.

Bagheri H, Simiand E, Montastruc JL, Magnaval JF. Bagheri H, et al. Ann Pharmacother. 2004 Mar;38(3):383-8. doi: 10.1345/aph.1D325. Epub 2004 Jan 23. Ann Pharmacother. 2004. PMID: 14749518

6

Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy.

Bagheri H, Fouladi A, Barange K, Lapeyre-Mestre M, Payen JL, Montastruc JL, Vinel JP. Bagheri H, et al. Pharmacotherapy. 2004 Nov;24(11):1546-53. doi: 10.1592/phco.24.16.1546.50947. Pharmacotherapy. 2004. PMID: 15537560

7

Trimetazidine: a new cause for drug-induced parkinsonism?

Sommet A, Azaïs-Vuillemin C, Bagheri H, Rascol O, Montastruc JL. Sommet A, et al. Among authors: bagheri h. Mov Disord. 2005 Aug;20(8):1080-1. doi: 10.1002/mds.20574. Mov Disord. 2005. PMID: 16007626 No abstract available.

8

Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.

Tavassoli N, Bagheri H, Sommet A, Delpierre C, Marion-Latard F, Massip P, Aquilina C, Bonnet E, Obadia M, Labau E, Montastruc JL, Bernard J. Tavassoli N, et al. Among authors: bagheri h. Pharmacotherapy. 2006 Feb;26(2):154-61. doi: 10.1592/phco.26.2.154. Pharmacotherapy. 2006. PMID: 16466321

9

[Setup of a national system of adverse drug reaction reporting in Lebanon: results of the first year of activity].

Kassab IA, Bouchi N, Bagheri H, Geahchan A. Kassab IA, et al. Among authors: bagheri h. Therapie. 2005 Nov-Dec;60(6):583-7. doi: 10.2515/therapie:2005082. Therapie. 2005. PMID: 16555497 French.

10

[Analysis of antiretroviral drugs-induced adverse effects].

Baudrant M, Bagheri H, Cuzin L, Sommet A, Bassoua V, Guitton E, Bonnet E, Garipuy D, Lucas F, Aquilina C, Montastruc JL, Massip P. Baudrant M, et al. Among authors: bagheri h. Therapie. 2006 Mar-Apr;61(2):171-6. Therapie. 2006. PMID: 16886711 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

628 results

Search Page